Alex Howarth

2021

In 2021, Alex Howarth earned a total compensation of $7.1M as Senior Vice President and Chief Financial Officer at Synta Pharmaceuticals.

Compensation breakdown

Bonus$75,000
Non-Equity Incentive Plan$241,200
Option Awards$6,526,500
Salary$281,250
Other$7,854
Total$7,131,804

Howarth received $6.5M in option awards, accounting for 92% of the total pay in 2021.

Howarth also received $75K in bonus, $241.2K in non-equity incentive plan, $281.3K in salary and $7.9K in other compensation.

Rankings

In 2021, Alex Howarth's compensation ranked 1,701st out of 12,406 executives tracked by ExecPay. In other words, Howarth earned more than 86.3% of executives.

ClassificationRankingPercentile
All
1,701
out of 12,406
86th
Division
Manufacturing
627
out of 5,492
89th
Major group
Chemicals And Allied Products
230
out of 2,368
90th
Industry group
Drugs
193
out of 2,089
91st
Industry
Pharmaceutical Preparations
130
out of 1,536
92nd

Pay ratio

Alex Howarth's Pay$7,131,804
Median Employee's Pay$459,419
Pay Ratio

16

to 1

In 2021, the annual total compensation of Alex Howarth was $7,131,804.

The annual total compensation of the median employee at Synta Pharmaceuticals was $459,419.

The ratio of Alex Howarth's pay to the pay of median employee was therefore 16 to one.

Source: SEC filing on May 2, 2022.

Howarth's colleagues

We found five more compensation records of executives who worked with Alex Howarth at Synta Pharmaceuticals in 2021.

2021

Paul Friedman

Synta Pharmaceuticals

Chief Executive Officer

2021

Rebecca Taub

Synta Pharmaceuticals

Chief Medical Officer

2021

Marc Schneebaum

Synta Pharmaceuticals

Chief Financial Officer

2021

Brian Lynch

Synta Pharmaceuticals

General Counsel

2021

Remy Sukhija

Synta Pharmaceuticals

Senior Vice President, Chief Commercial Officer

News

In-depth

You may also like